treprostinil 0.1 MG/ML Injectable Solution [Remodulin]

RxCUI: 2667750
RxNorm name: treprostinil 0.1 MG/ML Injectable Solution [Remodulin]
Display name: treprostinil 0.1 MG/ML Injectable Solution [Remodulin]
Full name: treprostinil 0.1 MG/ML Injectable Solution [Remodulin]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Remodulin	TREPROSTINIL	United Therapeutics Corporation	6c80bb38-e8db-4138-9f0d-dbbf9c673185	2026-07-02	Warnings, Adverse reactions	Exact identifier rxcui: 2667750

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
6c80bb38-e8db-4138-9f0d-dbbf9c673185	treprostinil 0.1 MG/ML Injectable Solution [Remodulin]	SBD	33	These highlights do not include all the information needed to use REMODULIN safely and effectively. See full prescribing information for REMODULIN. REMODULIN ® (treprostinil) Injection, for subcutaneous or intravenous use Initial U.S. Approval: May 2002	20250718
6c80bb38-e8db-4138-9f0d-dbbf9c673185	Remodulin 0.1 MG/ML Injectable Solution	PSN	33	These highlights do not include all the information needed to use REMODULIN safely and effectively. See full prescribing information for REMODULIN. REMODULIN ® (treprostinil) Injection, for subcutaneous or intravenous use Initial U.S. Approval: May 2002	20250718
6c80bb38-e8db-4138-9f0d-dbbf9c673185	Remodulin 0.1 MG/ML Injectable Solution	SY	33	These highlights do not include all the information needed to use REMODULIN safely and effectively. See full prescribing information for REMODULIN. REMODULIN ® (treprostinil) Injection, for subcutaneous or intravenous use Initial U.S. Approval: May 2002	20250718